Acupuncture for chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial.
10.13703/j.0255-2930.20221113-k0006
- Author:
Bo LI
1
;
Dong-Dong WANG
2
;
Xiao-di QIAO
3
;
Ai-Hong YUAN
4
;
Ping JIANG
5
;
Jiu-Ping XU
6
;
Jun YANG
4
;
Qing-Ping ZHANG
7
Author Information
1. Second Department of Acupuncture-Moxibustion and Rehabilitation, Anhui Hospital of Integrated Traditional Chinese and Western Medicine, Hefei 230031, China.
2. Tuina Department, Fuyang Hospital of TCM.
3. First Department of Acupuncture-Moxibustion and Rehabilitation, First Affiliated Hospital of Anhui University of CM.
4. Second Department of Acupuncture-Moxibustion and Rehabilitation, First Affiliated Hospital of Anhui University of CM.
5. Reproductive Medicine Centre, First Affiliated Hospital of Anhui University of CM.
6. Urology Surgery, First Affiliated Hospital of Anhui University of CM.
7. College of Acupuncture-Moxibustion and Tuina, Anhui University of CM, Hefei
- Publication Type:Journal Article
- Keywords:
acupuncture;
chronic prostatitis/chronic pelvic pain syndrome;
randomized controlled trial (RCT);
urinary flow rate
- MeSH:
United States;
Male;
Humans;
Prostatitis/therapy*;
Quality of Life;
Acupuncture Therapy;
Punctures;
Meridians
- From:
Chinese Acupuncture & Moxibustion
2023;43(6):654-658
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the short-term efficacy, long-term efficacy and safety of acupuncture for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
METHODS:Forty-two patients with CP/CPPS were randomly divided into an acupuncture group (21 cases, 1 case dropped off) and a sham acupuncture group (21 cases). The patients in the acupuncture group were treated with acupuncture at bilateral Zhongliao (BL 33), Huiyang (BL 35), Shenshu (BL 23) and Sanyinjiao (SP 6); the needling depth of Zhongliao (BL 33) and Huiyang (BL 35) was 60 to 80 mm, while Shenshu (BL 23) and Sanyinjiao (SP 6) was directly punctured of 30 mm. The patients in the sham acupuncture group were treated with acupuncture at non-acupoints, including points 2 cm next to Shenshu (BL 23), Zhongliao (BL 33) and Huiyang (BL 35), and the midpoint of the connecting line between the spleen meridian and the kidney meridian. All the non-acupoints were treated with directly puncture of 2 to 3 mm. The needles were left for 30 min in both groups, once every other day in the first four weeks, three times a week, and twice a week in the next four weeks, totally 20 treatments. Before treatment, after treatment and in follow-up of 24 weeks after treatment completion, the National Institutes of Health-chronic prostatitis symptom index (NIH-CPSI) score and urinary flow rate were observed in both groups; the clinical efficacy and safety were evaluated.
RESULTS:Compared with those before treatment, the pain and discomfort scores, urination symptoms scores, quality of life scores and total scores of NIH-CPSI in both groups were reduced after treatment in the two groups (P<0.01), while each item score and total score of NIH-CPSI in the acupuncture group were reduced in follow-up (P<0.01, P<0.05). After treatment and in follow-up, each item score and total score of NIH-CPSI in the acupuncture group were lower than those in the sham acupuncture group (P<0.05, P<0.01). After treatment, the maximum and average urinary flow rates in the acupuncture group were higher than those before treatment (P<0.05), and the average urinary flow rate in the acupuncture group was higher than that in the sham acupuncture group (P<0.05). The total effective rate was 75.0% (15/20) in the acupuncture group, which was higher than 42.9% (9/21) in the sham acupuncture group (P<0.05). No significant adverse reactions were observed in the two groups, and there was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).
CONCLUSION:Acupuncture could effectively alleviate the clinical symptoms, improve quality of life, and has a sustained, safe and reliable therapeutic effect in patients with CP/CPPS.
